Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Ebiomedicine|February 15, 2023
Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin interventionJesmond Dalli, Douglas Kitch, Meagan P O'Brien, et al.Journal of Virology|January 19, 2002
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infectionBluma G Brenner, Jean-Pierre Routy, Marco Petrella, et al.Science Advances|December 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1Michael L Freeman, Brian M Clagett, Konstantin Leskov, et al.Antiviral Research|June 15, 2010
Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypesEugene L Asahchop, Maureen Oliveira, Bluma G Brenner, et al.Open Forum Infectious Diseases|August 28, 2023
Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular DiseaseMichael L Freeman, Mian B Hossain, Shana A B Burrowes, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2018
Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral SuppressionMartin Hoenigl, Carlee B Moser, Nicholas Funderburg, et al.Open Forum Infectious Diseases|March 2, 2023
Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare WorkersMichael L Freeman, Oladayo A Oyebanji, Daniela Moisi, et al.Plos One|October 9, 2014
A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral loadHugues Charest, Florence Doualla-Bell, Régis Cantin, et al.Plos One|October 2, 2019
Pneumoproteins are associated with pulmonary function in HIV-infected personsDiane Jeon, Emily G Chang, Maggie McGing, et al.Open Forum Infectious Diseases|May 9, 2017
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral TherapyMeagan P O'Brien, Peter W Hunt, Douglas W Kitch, et al.Pageof 7